Acute intermittent porphyria. A case report. 1981

C Ganda, and P Joshi, and S Kramer

A case of acute intermittent porphyria is presented. This case emphasizes the clinical, biochemical and endocrinological changes, and their possible aetiology is discussed. Treatment, especially the use of intravenous haematin, is also described.

UI MeSH Term Description Entries
D008297 Male Males
D011162 Porphobilinogen
D011164 Porphyrias A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues. Porphyria,Porphyrin Disorder,Disorder, Porphyrin,Disorders, Porphyrin,Porphyrin Disorders
D003306 Coproporphyrins Porphyrins with four methyl and four propionic acid side chains attached to the pyrrole rings. Elevated levels of Coproporphyrin III in the urine and feces are major findings in patients with HEREDITARY COPROPORPHYRIA.
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000622 Aminolevulinic Acid A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. 5-Amino Levulinic Acid,5-Aminolaevulinate,5-Aminolevulinate,Aminolevulinic Acid Hydrochloride,Delta-Aminolevulinic Acid,Levulan,5 Amino Levulinic Acid,5 Aminolaevulinate,5 Aminolevulinate,Acid Hydrochloride, Aminolevulinic,Acid, 5-Amino Levulinic,Acid, Aminolevulinic,Acid, Delta-Aminolevulinic,Delta Aminolevulinic Acid,Hydrochloride, Aminolevulinic Acid,Levulinic Acid, 5-Amino

Related Publications

C Ganda, and P Joshi, and S Kramer
January 1977, Medicinski pregled,
C Ganda, and P Joshi, and S Kramer
March 1978, Singapore medical journal,
C Ganda, and P Joshi, and S Kramer
March 2020, Biomedica : revista del Instituto Nacional de Salud,
C Ganda, and P Joshi, and S Kramer
November 1973, East African medical journal,
C Ganda, and P Joshi, and S Kramer
August 1978, Zeitschrift fur arztliche Fortbildung,
C Ganda, and P Joshi, and S Kramer
June 1965, Indian pediatrics,
C Ganda, and P Joshi, and S Kramer
February 1951, United States Armed Forces medical journal,
C Ganda, and P Joshi, and S Kramer
April 1987, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
C Ganda, and P Joshi, and S Kramer
May 1982, Irish journal of medical science,
C Ganda, and P Joshi, and S Kramer
January 1984, Revista clinica espanola,
Copied contents to your clipboard!